Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 6/2014

01.06.2014 | Original Article – Cancer Research

JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis

verfasst von: You Wang, Ya-nan Yu, Shu Song, Tie-jun Li, Jing-ying Xiang, Hong Zhang, Mu-dan Lu, Fang Ji, Ling-qing Hu

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To elucidate the clinicopathological significance and the role of Jun Activation Domain-Binding Protein 1 (JAB1), Ser10-phosphorylated p27 (p27S10), and total p27 in human hepatocellular carcinoma (HCC) prognosis.

Methods

We evaluated the expression of JAB1 and p27S10 in tissues by immunohistochemical and immunoblot analyses. p27 Ser10 phosphorylation and Ser10 phosphorylation-dependent p27–JAB1 interaction were demonstrated in proliferating Huh7 cells following transfection of pEGFP-p27WT/p27S10A/p27S10D plasmids and pcDNA3.1-p27WT/p27S10A/p27S10D-Myc plasmids. Univariate and multivariate analysis were used to determine their role in HCC prognosis.

Results

JAB1 and p27S10 are overexpressed in HCC samples compared with paired normal tissues. There was a strong correlation between JAB1 and p27S10 expression (P < 0.001), and expression of both inversely correlated with total p27 levels (P < 0.001). High JAB1 and p27S10 expression correlated with histological grade, vascular invasion, and serum α-fetoprotein (AFP) level (all P < 0.01). Total p27 expression also correlated with histological tumor grade (P = 0.048) and AFP level (P = 0.015). The p27S10(high)/JAB1(high)/p27(1ow) profile was the most reliable indication of poor prognostic. Ser10 phosphorylation increased and total p27 levels decreased in a time-dependent manner in serum-starved Huh7 cells following addition of serum. Immunoprecipitation analysis revealed that p27 Ser-to-Asp substitution at position 10 (S10D) markedly enhanced the interaction between JAB1 and p27, but replacement of S10A reduced binding.

Conclusions

This study revealed that combined JAB1, p27S10, and total p27 expression may serve as a prognostic marker for HCC.
Literatur
Zurück zum Zitat Berg JP, Zhou Q, Breuhahn K, Schirmacher P, Patil MA, Chen X, Schafer N, Holler TT, Fischer HP, Buttner R, Gutgemann I (2007) Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma. Hum Pathol 38(11):1621–1627PubMedCrossRef Berg JP, Zhou Q, Breuhahn K, Schirmacher P, Patil MA, Chen X, Schafer N, Holler TT, Fischer HP, Buttner R, Gutgemann I (2007) Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma. Hum Pathol 38(11):1621–1627PubMedCrossRef
Zurück zum Zitat Blum HE (2002) Molecular targets for prevention of hepatocellular carcinoma. Dig Dis 20(1):81–90PubMedCrossRef Blum HE (2002) Molecular targets for prevention of hepatocellular carcinoma. Dig Dis 20(1):81–90PubMedCrossRef
Zurück zum Zitat Claret FX, Hibi M, Dhut S, Toda T, Karin M (1996) A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383(6599):5CrossRef Claret FX, Hibi M, Dhut S, Toda T, Karin M (1996) A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383(6599):5CrossRef
Zurück zum Zitat Edmondson HA, Peters RL (1983) Tumors of the liver: pathologic features. Semin Roentgenol 18(2):75–83PubMedCrossRef Edmondson HA, Peters RL (1983) Tumors of the liver: pathologic features. Semin Roentgenol 18(2):75–83PubMedCrossRef
Zurück zum Zitat Hengst L, Reed SI (1996) Translational control of p27Kip1 accumulation during the cell cycle. Science 271(5257):1861–1864PubMedCrossRef Hengst L, Reed SI (1996) Translational control of p27Kip1 accumulation during the cell cycle. Science 271(5257):1861–1864PubMedCrossRef
Zurück zum Zitat Ishida N, Kitagawa M, Hatakeyama S, Nakayama K (2000) Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability. J Biol Chem 275(33):9CrossRef Ishida N, Kitagawa M, Hatakeyama S, Nakayama K (2000) Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability. J Biol Chem 275(33):9CrossRef
Zurück zum Zitat Ishida N, Hara T, Kamura T, Yoshida M, Nakayama K, Nakayama KI (2002) Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem 277(17):4CrossRef Ishida N, Hara T, Kamura T, Yoshida M, Nakayama K, Nakayama KI (2002) Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem 277(17):4CrossRef
Zurück zum Zitat Lai EC, Lau WY (2005) The continuing challenge of hepatic cancer in Asia. Surgeon 3(3):210–215PubMedCrossRef Lai EC, Lau WY (2005) The continuing challenge of hepatic cancer in Asia. Surgeon 3(3):210–215PubMedCrossRef
Zurück zum Zitat Lau WY, Lai EC (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7(3):237–257PubMed Lau WY, Lai EC (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7(3):237–257PubMed
Zurück zum Zitat Lee JG, Kay E (2007) Two populations of p27 use differential kinetics to phosphorylate Ser-10 and Thr-187 via phosphatidylinositol 3-Kinase in response to fibroblast growth factor-2 stimulation. J Biol Chem 282(9):11 Lee JG, Kay E (2007) Two populations of p27 use differential kinetics to phosphorylate Ser-10 and Thr-187 via phosphatidylinositol 3-Kinase in response to fibroblast growth factor-2 stimulation. J Biol Chem 282(9):11
Zurück zum Zitat Matsumata T, Kanematsu T, Shirabe K, Sonoda T, Furuta T, Sugimachi K (1990) Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma. Br J Surg 77(6):677–680PubMedCrossRef Matsumata T, Kanematsu T, Shirabe K, Sonoda T, Furuta T, Sugimachi K (1990) Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma. Br J Surg 77(6):677–680PubMedCrossRef
Zurück zum Zitat Medema RH, Kops GJ, Bos JL, Burgering BM (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404(6779):782–787PubMedCrossRef Medema RH, Kops GJ, Bos JL, Burgering BM (2000) AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404(6779):782–787PubMedCrossRef
Zurück zum Zitat Naka T, Toyota N, Kaneko T, Kaibara N (1998) Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res 18(1B):10 Naka T, Toyota N, Kaneko T, Kaibara N (1998) Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma. Anticancer Res 18(1B):10
Zurück zum Zitat Nishida N, Fukuda Y, Ishizaki K, Nakao K (1997) Alteration of cell cycle-related genes in hepatocarcinogenesis. Histol Histopathol 12(4):1019–1025PubMed Nishida N, Fukuda Y, Ishizaki K, Nakao K (1997) Alteration of cell cycle-related genes in hepatocarcinogenesis. Histol Histopathol 12(4):1019–1025PubMed
Zurück zum Zitat Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269(5224):682–685PubMedCrossRef Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M (1995) Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269(5224):682–685PubMedCrossRef
Zurück zum Zitat Patil MA, Gütgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, Kakar S, Furge KA, Büttner R, Chen X (2005) Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 26(12):8CrossRef Patil MA, Gütgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, Kakar S, Furge KA, Büttner R, Chen X (2005) Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 26(12):8CrossRef
Zurück zum Zitat Rodier G, Montagnoli A, Di Marcotullio L, Coulombe P, Draetta GF, Pagano M, Meloche S (2001) p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J 20(23):11CrossRef Rodier G, Montagnoli A, Di Marcotullio L, Coulombe P, Draetta GF, Pagano M, Meloche S (2001) p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J 20(23):11CrossRef
Zurück zum Zitat Scudamore CH, Ragaz J, Kluftinger AM, Owen DA (1988) Hepatocellular carcinoma. A comparison of Oriental and Caucasian patients. Am J Surg 155(5):659–662PubMedCrossRef Scudamore CH, Ragaz J, Kluftinger AM, Owen DA (1988) Hepatocellular carcinoma. A comparison of Oriental and Caucasian patients. Am J Surg 155(5):659–662PubMedCrossRef
Zurück zum Zitat Sgambato A, Cittadini A, Faraglia B, Weinstein IB (2000) Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J Cell Physiol 183(1):18–27PubMedCrossRef Sgambato A, Cittadini A, Faraglia B, Weinstein IB (2000) Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J Cell Physiol 183(1):18–27PubMedCrossRef
Zurück zum Zitat Shirane M, Harumiya Y, Ishida N, Hirai A, Miyamoto C, Hatakeyama S, Nakayama K, Kitagawa M (1999) Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 274(20):13886–13893PubMedCrossRef Shirane M, Harumiya Y, Ishida N, Hirai A, Miyamoto C, Hatakeyama S, Nakayama K, Kitagawa M (1999) Down-regulation of p27(Kip1) by two mechanisms, ubiquitin-mediated degradation and proteolytic processing. J Biol Chem 274(20):13886–13893PubMedCrossRef
Zurück zum Zitat The Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg 211(3):277–287 The Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg 211(3):277–287
Zurück zum Zitat Tomoda K, Kubota Y, Kato J (1999) Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398(6728):6 Tomoda K, Kubota Y, Kato J (1999) Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398(6728):6
Zurück zum Zitat Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N, Kato JY (2002) The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem 277(3):2302–2310PubMedCrossRef Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N, Kato JY (2002) The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem 277(3):2302–2310PubMedCrossRef
Zurück zum Zitat Wang Y, Wang Y, Cheng C, Ji Y, Zhao Y, Zou L, Shen A (2009) Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma. J Cancer Res Clin Oncol 135(7):951–959PubMedCrossRef Wang Y, Wang Y, Cheng C, Ji Y, Zhao Y, Zou L, Shen A (2009) Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma. J Cancer Res Clin Oncol 135(7):951–959PubMedCrossRef
Zurück zum Zitat Wang Y, Wang Y, Xiang J, Ji F, Deng Y, Tang C, Yang S, Xi Q, Liu R, Di W (2014) Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer. Cancer Lett 343(1):6–13PubMedCrossRef Wang Y, Wang Y, Xiang J, Ji F, Deng Y, Tang C, Yang S, Xi Q, Liu R, Di W (2014) Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer. Cancer Lett 343(1):6–13PubMedCrossRef
Zurück zum Zitat Xu X, Yamamoto H, Sakon M, Yasui M, Ngan CY, Fukunaga H, Morita T, Ogawa M, Nagano H, Nakamori S, Sekimoto M, Matsuura N, Monden M (2003) Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas. Clin Cancer Res 9(5):9 Xu X, Yamamoto H, Sakon M, Yasui M, Ngan CY, Fukunaga H, Morita T, Ogawa M, Nagano H, Nakamori S, Sekimoto M, Matsuura N, Monden M (2003) Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas. Clin Cancer Res 9(5):9
Zurück zum Zitat Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, Fujimoto J, Oriyama T, Furukawa K, Kawamura E (1990) Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 65(5):1104–1110PubMedCrossRef Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, Fujimoto J, Oriyama T, Furukawa K, Kawamura E (1990) Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis. Cancer 65(5):1104–1110PubMedCrossRef
Metadaten
Titel
JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis
verfasst von
You Wang
Ya-nan Yu
Shu Song
Tie-jun Li
Jing-ying Xiang
Hong Zhang
Mu-dan Lu
Fang Ji
Ling-qing Hu
Publikationsdatum
01.06.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 6/2014
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-014-1646-y

Weitere Artikel der Ausgabe 6/2014

Journal of Cancer Research and Clinical Oncology 6/2014 Zur Ausgabe

Original Article – Clinical Oncology

Primary malignant cardiac tumors

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.